Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Braster S.A. produces and sells at-home breast cancer examination devices worldwide. It provides Braster System, an in-home breast examination system for individual customers; and Braster Pro, a breast examination system for professional use by healthcare professionals. The company was formerly known as BRASTER spólka z ograniczona odpowiedzialnoscia and changed its name to Braster S.A. in December 2012. Braster S.A. was founded in 2008 and is headquartered in Ozarów Mazowiecki, Poland.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Buy
Sell